GHC vs. WST
Compare and contrast key facts about Graham Holdings Company (GHC) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GHC or WST.
Correlation
The correlation between GHC and WST is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GHC vs. WST - Performance Comparison
Key characteristics
GHC:
0.99
WST:
-0.34
GHC:
1.64
WST:
-0.23
GHC:
1.19
WST:
0.97
GHC:
2.02
WST:
-0.32
GHC:
5.15
WST:
-0.64
GHC:
5.71%
WST:
20.50%
GHC:
29.47%
WST:
38.59%
GHC:
-67.54%
WST:
-55.52%
GHC:
-2.13%
WST:
-29.26%
Fundamentals
GHC:
$4.07B
WST:
$23.97B
GHC:
$52.44
WST:
$6.62
GHC:
17.89
WST:
50.01
GHC:
0.00
WST:
6.29
GHC:
$3.55B
WST:
$2.14B
GHC:
$1.00B
WST:
$726.20M
GHC:
$546.34M
WST:
$535.00M
Returns By Period
In the year-to-date period, GHC achieves a 7.80% return, which is significantly higher than WST's 1.06% return. Over the past 10 years, GHC has underperformed WST with an annualized return of 6.03%, while WST has yielded a comparatively higher 21.15% annualized return.
GHC
7.80%
5.74%
33.14%
33.81%
12.51%
6.03%
WST
1.06%
-1.35%
8.80%
-16.59%
15.93%
21.15%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GHC vs. WST — Risk-Adjusted Performance Rank
GHC
WST
GHC vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Graham Holdings Company (GHC) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GHC vs. WST - Dividend Comparison
GHC's dividend yield for the trailing twelve months is around 0.74%, more than WST's 0.18% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GHC Graham Holdings Company | 0.74% | 0.79% | 0.95% | 1.05% | 0.96% | 1.09% | 0.87% | 0.83% | 0.91% | 0.95% | 1.77% | 1.18% |
WST West Pharmaceutical Services, Inc. | 0.18% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
Drawdowns
GHC vs. WST - Drawdown Comparison
The maximum GHC drawdown since its inception was -67.54%, which is greater than WST's maximum drawdown of -55.52%. Use the drawdown chart below to compare losses from any high point for GHC and WST. For additional features, visit the drawdowns tool.
Volatility
GHC vs. WST - Volatility Comparison
Graham Holdings Company (GHC) and West Pharmaceutical Services, Inc. (WST) have volatilities of 6.86% and 7.10%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GHC vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Graham Holdings Company and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities